Israel Englander Concert Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.34 - $5.84 $530,465 - $713,805	122,227 Added 9.26%	1,441,735 $8.42 Million
Q3 2022 Nov 14, 2022	BUY	$4.27 - $7.2 $328,499 - $553,910	76,932 Added 6.19%	1,319,508 $8.84 Million
Q2 2022 Aug 15, 2022	SELL	$2.8 - $6.36 $7,940 - $18,036	-2,836 Reduced 0.23%	1,242,576 $5.23 Million
Q1 2022 May 16, 2022	SELL	$2.73 - $3.94 $283,420 - $409,038	-103,817 Reduced 7.69%	1,245,412 $4.2 Million
Q4 2021 Feb 14, 2022	BUY	$2.69 - $4.22 $596,101 - $935,147	221,599 Added 19.65%	1,349,229 $4.25 Million
Q3 2021 Nov 15, 2021	SELL	$3.17 - $4.15 $487,029 - $637,593	-153,637 Reduced 11.99%	1,127,630 $3.69 Million
Q2 2021 Aug 16, 2021	BUY	$3.77 - $5.24 $1.03 Million - $1.44 Million	274,027 Added 27.21%	1,281,267 $5.41 Million
Q1 2021 May 17, 2021	BUY	$4.86 - $13.07 $568,556 - $1.53 Million	116,987 Added 13.14%	1,007,240 $5.03 Million
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $1.44 Million - $1.95 Million	-151,630 Reduced 14.55%	890,253 $11.3 Million
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $1.54 Million - $1.92 Million	-177,855 Reduced 14.58%	1,041,883 $10.2 Million
Q2 2020 Aug 14, 2020	BUY	$7.8 - $11.52 $848,624 - $1.25 Million	108,798 Added 9.79%	1,219,738 $12.1 Million
Q1 2020 May 14, 2020	BUY	$5.98 - $13.09 $4.24 Million - $9.28 Million	709,310 Added 176.61%	1,110,940 $9.82 Million
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $190,171 - $307,072	33,305 Added 9.04%	401,630 $3.71 Million
Q3 2019 Nov 14, 2019	SELL	$5.88 - $12.35 $918,685 - $1.93 Million	-156,239 Reduced 29.78%	368,325 $2.17 Million
Q2 2019 Aug 14, 2019	SELL	$9.44 - $13.12 $2.85 Million - $3.97 Million	-302,304 Reduced 36.56%	524,564 $6.3 Million
Q1 2019 May 14, 2019	SELL	$12.07 - $17.54 $2.23 Million - $3.24 Million	-184,885 Reduced 18.27%	826,868 $9.98 Million
Q4 2018 Feb 14, 2019	BUY	$11.25 - $16.17 $5.3 Million - $7.62 Million	471,312 Added 87.21%	1,011,753 $12.7 Million
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $1.52 Million - $2.12 Million	-118,711 Reduced 18.01%	540,441 $8.02 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $3.82 Million - $4.92 Million	227,269 Added 52.62%	659,152 $11.1 Million
Q1 2018 May 15, 2018	SELL	$19.24 - $28.03 $5.66 Million - $8.24 Million	-294,002 Reduced 40.5%	431,883 $9.89 Million
Q4 2017 Feb 14, 2018	BUY	$13.96 - $29.05 $7.02 Million - $14.6 Million	503,066 Added 225.77%	725,885 $18.8 Million
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $3.1 Million - $3.41 Million	222,819	222,819 $3.29 Million

Others Institutions Holding CNCE

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About CONCERT PHARMACEUTICALS, INC.

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

More about CNCE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account